Cisco Systems (CSCO) 29.54 $CSCO Most active

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cisco Systems (CSCO) 29.54 $CSCO

Most active Nasdaq-traded stocks
AP - 1 hr 51 mins ago
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
SPLS: 16.81 (-0.20), OREX: 7.64 (+1.85), MU: 29.66 (-1.58), ONCY: 1.16 (+0.09), FB: 79.60 (-0.15), ARCP: 10.08 (+0.18), ZNGA: 2.35 (+0.03), MSFT: 43.28 (-0.60), INTC: 34.10 (+0.04), AAPL: 129.36 (+0.27), CSCO: 29.54 (-0.65)

Hewlett-Packard Confirms Aruba Networks Buyout Rumors - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 2:29PM CST
Last week's much-hyped speculation regarding the acquisition of wireless networking solution provider Aruba Networks Inc. (ARUN) by Hewlett-Packard Company (HPQ) were finally put to rest after the latter confirmed it yesterday.
ARUN: 24.41 (-0.24), HPQ: 34.57 (-0.35), CSCO: 29.54 (-0.65), JNPR: 23.88 (-0.13)

Dow Jones (DJIA) Today: Cisco Systems (CSCO) Lower
at The Street - Tue Mar 03, 1:00PM CST
Holding back the Dow today is Cisco Systems (Nasdaq:CSCO), which is lagging the broader Dow index with a 64-cent decline (-2.1%) bringing the stock to $29.55.
CSCO: 29.54 (-0.65)

Would GE Shareholders Be Better Off Without CEO Jeff Immelt?
at The Street - Tue Mar 03, 11:52AM CST
Despite what some investors believe, Immelt is being pushed to fall on his sword too soon.
T: 34.41 (-0.23), JNJ: 102.34 (-0.88), GE: 25.86 (-0.25), SPY: 211.12 (-0.87), MSFT: 43.28 (-0.60), INTC: 34.10 (+0.04), CVX: 105.16 (-0.74), VZ: 49.55 (+0.08), CSCO: 29.54 (-0.65)

Nasdaq Hits 5000: 3 Choices to Ride the Upswing - Analyst Blog
Swarup Gupta - Zacks Investment Research - Tue Mar 03, 10:36AM CST
Echoes of the dot-com boom could be heard yesterday after the Nasdaq closed above 5,000 for the first time in 15 years.
AMZN: 384.61 (-1.04), BIIB: 412.79 (-3.00), FB: 79.60 (-0.15), AMGN: 158.56 (-1.07), H: 61.26 (-0.50), INTC: 34.10 (+0.04), PCLN: 1,242.03 (-7.37), CELG: 118.47 (-1.84), SBUX: 94.00 (-0.22), GILD: 102.79 (-1.04), MSFT: 43.28 (-0.60), AAPL: 129.36 (+0.27), CSCO: 29.54 (-0.65), ONNN: 12.87 (-0.29)

Palo Alto Networks (PANW) Q2 Loss Widens, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 9:10AM CST
Palo Alto Networks, Inc. (PANW) reported second-quarter fiscal 2015 adjusted loss per share of 42 cents per share, which was greater than the Zacks Consensus Estimate of a loss of 13 cents per share.
PANW: 148.90 (+2.92), CSCO: 29.54 (-0.65), CHKP: 83.22 (-1.13), JNPR: 23.88 (-0.13)

CHALLENGE UP! - Cisco, Deutsche Telekom and Intel Announce Joint Startup Program
M2 - Tue Mar 03, 6:50AM CST
Today at Mobile World Congress, Cisco, Deutsche Telekom and Intel announced Challenge Up!, a joint Internet of Things (IoT) accelerator for startups from the Europe, Middle East and Africa (EMEA) region. The program aims at helping innovative IoT startups go-to-market faster through joint projects, mentoring, high-value networking and corporate assets. Selected companies may also recieve strategic investment and support commercializing their product or service for global markets.
INTC: 34.10 (+0.04), CSCO: 29.54 (-0.65)

Deutsche Telekom, Cisco Announce the Launch of DT's Cloud VPN Service in Three European Countries
Marketwired - Tue Mar 03, 5:00AM CST
At Mobile World Congress, Deutsche Telekom (DT) announced the launch of a Cloud VPN (Virtual Private Network) Service for small and medium businesses. The announcement builds on the longstanding collaboration between DT and Cisco (NASDAQ: CSCO). The Cloud VPN offering is DT's first commercial service based on its centralized Pan-European IP network. It was designed and developed using a collaborative "devops" philosophy by Cisco and DT. The service is first available to customers via DT's subsidiaries in Croatia, Hungary and Slovakia from March 2.
CSCO: 29.54 (-0.65)

'Fast Money' Recap: Nasdaq Closes Over 5,000? Now What?
at The Street - Tue Mar 03, 4:00AM CST
The trading panel discussed what technology and biotech stocks to buy and what Tesla should do next.
KO: 42.95 (-0.25), TSLA: 199.56 (+2.24), QQQ: 108.87 (-0.51), EBAY: 58.26 (-0.12), BRCM: 45.43 (-0.76), GM: 37.80 (+0.19), GOOGL: 578.79 (+3.77), BAC: 16.04 (+0.03), IWM: 122.74 (-0.73), MSFT: 43.28 (-0.60), INTC: 34.10 (+0.04), AAPL: 129.36 (+0.27), CSCO: 29.54 (-0.65)

Telecom Italia and Cisco Announce Intent to Enter Agreement to Offer Innovative Cloud Services to Italian Organizations
Marketwired - Tue Mar 03, 1:01AM CST
At Mobile World Congress 2015, Telecom Italia and Cisco (NASDAQ: CSCO) announced that Telecom Italia intends to deliver new Cisco-enabled managed business services, including Cisco Meraki, to organizations throughout Italy as part of its innovative LAN management offering.
CSCO: 29.54 (-0.65)

Cisco Small Cells Set to Benefit EE Enterprise Customers
Marketwired - Tue Mar 03, 1:01AM CST
At Mobile World Congress 2015, Cisco (NASDAQ: CSCO) today announced that EE, the UK's largest mobile network operator, is deploying Cisco small cells to support its growing base of enterprise customers. Cisco's end-to-end small cell solutions will scale to be suitable for small, medium and large enterprise buildings.
CSCO: 29.54 (-0.65)

China Won't Be Faking It Much Longer
Paulo Santos - at Seeking Alpha - Tue Mar 03, 1:01AM CST

MSFT: 43.28 (-0.60), HPQ: 34.57 (-0.35), AAPL: 129.36 (+0.27), CSCO: 29.54 (-0.65), FXI: 42.70 (-1.15)

How "Android for Work" Could Help Google Inc. Gain Ground in Enterprise
Leo Sun, The Motley Fool - Motley Fool - Mon Mar 02, 7:36PM CST
Google Android devices accounted for 81.5% of the smartphone market in 2014, according to IDC. However, Android still isn't considered a serious enterprise platform for companies due to concerns about security and fragmentation....
BOX: 18.59 (-0.20), BBRY: 10.97 (-0.08), PANW: 148.90 (+2.92), GOOG: 573.64 (+2.30), ADBE: 78.99 (-0.80), CTXS: 62.42 (-1.25), SAP: 70.41 (-0.70), IBM: 161.03 (+0.55), FFIV: 119.01 (-0.55), GOOGL: 578.79 (+3.77), MSFT: 43.28 (-0.60), AAPL: 129.36 (+0.27), CSCO: 29.54 (-0.65), CRM: 66.95 (-1.51)

Polycom to Gain from RealPresence Growth, Competition Rife - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 4:47PM CST
On Feb 27, 2015, we issued an updated research report on Polycom, Inc. (PLCM).
T: 34.41 (-0.23), IDCC: 55.44 (+1.38), PLCM: 13.55 (-0.35), CSCO: 29.54 (-0.65)

HP Acquisitions May Not End With Aruba Networks
at Investor's Business Daily - Mon Mar 02, 3:51PM CST
Hewlett-Packard is taking aim at Cisco Systems with its bid to buy Aruba Networks, but HP might not be done making acquisitions before its split-up, analysts say. The struggling computer maker early Monday confirmed plans to acquire Aruba for $24.67...
RKUS: 12.21 (-0.05), HPQ: 34.57 (-0.35), CSCO: 29.54 (-0.65)

Look for Shares of Cisco Systems to Potentially Pullback after Yesterday's 2.30% Rise
Comtex SmarTrend(R) - Mon Mar 02, 3:39PM CST
Cisco Systems (NASDAQ:CSCO) traded in a range yesterday that spanned from a low of $29.34 to a high of $30.31. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $29.99 on volume of 35.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CSCO: 29.54 (-0.65)

Cisco Systems Set to Possibly Pullback After Yesterday's Rally of 2.30%
Comtex SmarTrend(R) - Mon Mar 02, 3:39PM CST
Cisco Systems (NASDAQ:CSCO) traded in a range yesterday that spanned from a low of $29.34 to a high of $30.31. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $29.99 on volume of 35.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CSCO: 29.54 (-0.65)

Cisco tops $30; new mobile products launched at MWC
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 3:12PM CST

CSCO: 29.54 (-0.65)

Nasdaq 5,000 Is Signaling a 'Broader' Bull Market in Stocks
at The Street - Mon Mar 02, 1:40PM CST
Almost 15 years to the day in which the Nasdaq Composite hit a record high, the index hit the 5,000-mark on Monday -- the first time since its bust.
YHOO: 42.62 (-1.49), GILD: 102.79 (-1.04), FB: 79.60 (-0.15), QCOM: 71.40 (-1.25), AMAT: 24.49 (-1.14), JDSU: 13.51 (-0.30), GOOGL: 578.79 (+3.77), MSFT: 43.28 (-0.60), INTC: 34.10 (+0.04), AAPL: 129.36 (+0.27), ORCL: 43.38 (-0.65), CSCO: 29.54 (-0.65)

Nasdaq Has Room to Run Over 5,000, Lumber Liquidators Crushed
at The Street - Mon Mar 02, 1:29PM CST
The CNBC 'Fast Money Halftime' traders discussed whether the Nasdaq can go yet higher.
AMZN: 384.61 (-1.04), HD: 116.07 (-0.05), FB: 79.60 (-0.15), FRC: 57.46 (unch), LL: 40.78 (+1.95), INTC: 34.10 (+0.04), TLT: 126.41 (-0.46), CME: 97.09 (-0.03), SPY: 211.12 (-0.87), QQQ: 108.87 (-0.51), DIA: 181.87 (-0.81), LOW: 75.01 (-0.08), BP: 41.74 (+0.44), IWM: 122.74 (-0.73), MSFT: 43.28 (-0.60), AAPL: 129.36 (+0.27), CSCO: 29.54 (-0.65)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Enanta Pharmaceuticals Highlights Fiscal Q1 2025 Performance

Updated Category News Views 188

Enanta Pharmaceuticals Reports Financial Highlights for Q1 2025 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology firm, has revealed its financial results for the first fiscal quarter ending December 31, 2024. This quarter is seen as a crucial period for the company as it expands its innovative drug portfolio targeting viral and immunological...

Continue Reading
Friedman Industries Reports Impressive First Quarter Growth

Updated Category News Views 98

Friedman Industries Reports Significant First Quarter Growth Friedman Industries, Incorporated (NASDAQ/GS: FRD) has announced remarkable results for the first quarter of the fiscal year, showcasing a strong performance that has positioned the company favorably in the steel manufacturing sector. The results released highlight not only the growth in earnings but also an...

Continue Reading
From Doubt to Delicious: The Rise of Raising Cane's

Updated Category News Views 308

Overcoming Doubt: The Birth of Raising Cane's The journey of Raising Cane's is not just about chicken fingers; it's a story of perseverance. Founded by Todd Graves, the chain has become a testament to how challenges can fuel passion and success. Graves faced significant skepticism from those who thought the concept was flawed due to its limited menu. Motivation Behind...

Continue Reading
Understanding Japan's Impact on US Tech Stock Dynamics

Updated Category News Views 371

The Influence of Japan's Real Rates on US Markets The current landscape of the S&P 500 bull market has been subject to various influences, and surprisingly, one of the most significant factors is not a domestic recession in the US but rather Japan's extraordinarily negative real interest rates compared to those in the US. This insightful perspective comes from BCA...

Continue Reading
Ocean Ledger Secures Funding to Enhance Coastal Risk Solutions

Updated Category News Views 171

Ocean Ledger Secures Funding for Coastal Risk Management Ocean Ledger, a promising geospatial analytics startup, has recently completed a successful funding round, securing $900K to enhance its capabilities in coastal risk management. This investment is poised to support the development of innovative solutions aimed at forecasting coastal risks, benefitting various...

Continue Reading